Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump
- 2 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Langenbecks Archives Of Surgery
- Vol. 395 (1), 65-71
- https://doi.org/10.1007/s00423-008-0437-9
Abstract
Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is safe and effective in selected subjects with diabetes. Our aim was to assess surgical experience and complications with CIPII. We performed a retrospective longitudinal observational cohort study of patients that started with CIPII from 1990 to 2006. Operation free period and complication rate were compared between patients initiating CIPII before 2000 and from 2000 onwards. In 63 patients, 166 re-operations were performed during 381 patient-years. Re-operations were pump replacement due to end-of-battery life (47%), laparoscopic catheter-related procedures (29%) and other interventions (24%). Median operation free period increased from 21 to 78 months from 2000 onwards (p = 0.039). Nineteen percent of patients developed complications. No operation-related mortality was reported. Increased experience together with technical improvements has led to an increase of the operation free period. The absence of procedure-related mortality and a low complication rate makes CIPII feasible for selected patients with diabetes.Keywords
This publication has 18 references indexed in Scilit:
- Implantable insulin pumps. A position statement about their clinical useDiabetes & Metabolism, 2007
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Surgical experience with implantable insulin pumpsThe American Journal of Surgery, 1998
- Long-Term Therapy of IDDM With an Implantable Insulin PumpDiabetes Care, 1997
- Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patientsAmerican Journal Of Medicine, 1996
- A Cost-Benefit Comparison of Intensive Diabetes Management With Implantable Pumps Versus Multiple Subcutaneous Injections in Patients With Type I DiabetesDiabetes Care, 1994
- French multicentre experience of implantable insulin pumpsThe Lancet, 1994
- Clinical Trial of Programmable Implantable Insulin Pump For Type I DiabetesDiabetes Care, 1992
- Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic PatientsDiabetes Care, 1992
- Normalization of Plasma Insulin Profiles in Diabetic Subjects with Programmed Insulin DeliveryDiabetes Care, 1980